Dr. Spiera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1088 Park Avenue
New York, NY 10128Phone+1 212-860-2100Fax+1 212-722-7365
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1992 - 1995
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
- Yale School of MedicineClass of 1989
- Columbia CollegeB.A., Summa Cum Laude, 1981 - 1985
Certifications & Licensure
- NY State Medical License 1991 - 2025
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Rheumatology Teacher of the Year 2006
- Join now to see all
Clinical Trials
- Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Start of enrollment: 2007 Aug 01
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Start of enrollment: 2011 Jan 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- 479 citationsEfficacy of Remission-Induction Regimens for ANCA-associated VasculitisUlrich Specks, Peter A. Merkel, Philip Seo, Robert Spiera, Carol A. Langford
The New England Journal of Medicine. 2013-07-31 - 1692 citationsRituximab versus Cyclophosphamide for ANCA-Associated VasculitisJohn H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford
The New England Journal of Medicine. 2010-07-15 - 108 citationsFactors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.Lynn A. Fussner, Amber M. Hummel, Darrell R. Schroeder, Francisco Silva, Rodrigo Cartin-Ceba
Arthritis & Rheumatology. 2016-07-01
Journal Articles
- The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma CohortsDaniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
- Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaSullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Walla..., N Engl J Med, 1/4/2018
- A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu ArteritisLangford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pa..., Arthritis Rheumatol, 1/30/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Outcome Measures in Giant Cell Arteritis and Polymyalgia RheumaticaSpiera RF, Fourth International Symposium on Giant Cell Arteritis & Polymyalgia Rheumatica, 1/1/2008
- Extraintestinal Manifestations of Inflammatory Bowel DiseaseSpiera RF, American College of Gastroenterology, 1/1/2001
- Ticlopidine Induced SLE: A Report of Four CasesSpiera RF, ACR National Meeting, 1/1/2000
- Join now to see all
Lectures
- VasculitisMultiple locations, 2002, 2003, 2004, 2007, 2015, 2016 - 1/1/2016
- Temporal ArteritisMultiple locations, 2000, 2001, 2009, 2013, 2014 - 1/1/2014
- Participating in Research-How it Works & What is out ThereNew York, NY - 1/1/2014
- Join now to see all
Authored Content
- Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)November 2022
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Join now to see all
Press Mentions
- New Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on SteroidsJuly 25th, 2024
- Steroids’ 75th Anniversary: Clinicians Strive to Use LessJuly 25th, 2024
- Lenabasum Improved Skin Symptoms in Dermatomyositis, but Future Is UncertainMay 17th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: